Attention asthmatics! The Main Pharmaceutical Inspectorate decided to withdraw a series of popular agent used in the treatment of asthma. What was the reason for the decision?
It concerns the product Asaris inhalation powder (500 pg + 50 pg / inhalation dose, batch number: 223015015. The manufacturer of the drug is Polfarmex SA The reason for the decision is the jamming of the inhaler dosing mechanism. Therefore, the batch of the drug must be removed from pharmacies.